IASR Vol.42, No.3 (No.493), March 2021 Multidrug-Resistant Acinetobacter Infection

IASR Vol. 42,
No.3 (No. 493) March 2021
No.3 (No. 493) March 2021
Multidrug-Resistant Acinetobacter Infection
- Drug resistance mechanisms and testing of Acinetobacter spp.
- Current situation of MDRA overseas with a focus on Asia
- Measures to prevent nosocomial spread of imported drug-resistant bacteria
- Commentary: Acinetobacter bereziniae
- Case report of a patient with TMB-1 metallo-β-lactamase-producing Acinetobacter pittii
- Findings on multidrug-resistant Acinetobacter from Japan Nosocomial Infections Surveillance data
- Treatment of patients with multidrug-resistant Acinetobacter infection
- SARS-CoV-2 genome surveillance in Japan (as at 14 January 2021)
- An outbreak of tellurite-susceptible enterohemorrhagic Escherichia coli O103 in a nursery school, Osaka City
- The first case of Haemophilus influenzae type a isolated from a pediatric patient with invasive Haemophilus influenzae disease in Japan, Tokyo Prefecture